Prudential Financial Inc Quanterix Corp Transaction History

Prudential Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.26 - $23.78 $2.22 Million - $4.31 Million	-181,225 Reduced 63.25%	105,288 $1.39 Million
Q1 2024 May 14, 2024	SELL	$21.9 - $28.28 $2.27 Million - $2.93 Million	-103,680 Reduced 26.57%	286,513 $6.75 Million
Q4 2023 Feb 13, 2024	SELL	$19.54 - $28.66 $490,649 - $719,652	-25,110 Reduced 6.05%	390,193 $10.7 Million
Q3 2023 Nov 13, 2023	BUY	$21.15 - $27.96 $8.23 Million - $10.9 Million	389,180 Added 1489.8%	415,303 $11.3 Million
Q2 2023 Aug 11, 2023	SELL	$11.16 - $23.65 $11,606 - $24,596	-1,040 Reduced 3.83%	26,123 $589,000
Q1 2023 May 12, 2023	BUY	$10.12 - $14.91 $121,439 - $178,920	12,000 Added 79.14%	27,163 $306,000
Q4 2022 Feb 14, 2023	BUY	$8.75 - $14.02 $132,676 - $212,585	15,163 New	15,163 $0

157

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $348M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.